All News #Library
Others
Novartis Announces Expiration Of Tourmaline Bio Tender Offer
28 Oct 2025 //
GLOBENEWSWIRE
Novartis Completes Acquisition Of Tourmaline Bio
28 Oct 2025 //
GLOBENEWSWIRE
Novartis Completes Hart-Scott-Rodino Waiting Period
22 Oct 2025 //
GLOBENEWSWIRE
Novartis Initiates Tender Offer For Tourmaline Bio Acquisition
29 Sep 2025 //
GLOBENEWSWIRE
Novartis to Acquire Tourmaline Bio for $1.4 Billion
09 Sep 2025 //
REUTERS
Tourmaline Add Dr. Paul To Cardiovascular Scientific Advisory Board
10 Jan 2025 //
GLOBENEWSWIRE
Tourmaline Bio Announces the Promotion of Ryan Robinson to CCFO
27 Jun 2024 //
GLOBENEWSWIRE
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
23 May 2024 //
GLOBENEWSWIRE
Tourmaline Bio Reports Q1 2024 Results, Business Highlights
13 May 2024 //
GLOBENEWSWIRE
Tourmaline Bio Reports4Q FYR 2023 & Recent Business Highlights
19 Mar 2024 //
GLOBENEWSWIRE
Tourmaline Bio to Present at Upcoming Investor Conferences
27 Feb 2024 //
GLOBENEWSWIRE
Tourmaline Bio to Present at the 6th Annual Biotechnology Conference
01 Feb 2024 //
GLOBENEWSWIRE
Tourmaline Announces Closing of $172.5 Million Public Offering of Common Stock
29 Jan 2024 //
GLOBENEWSWIRE
Tourmaline Bio Announces Pricing of Public Offering of Common Stock
25 Jan 2024 //
GLOBENEWSWIRE
Tourmaline Bio Announces Proposed Public Offering of Common Stock
24 Jan 2024 //
GLOBENEWSWIRE
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
14 Dec 2023 //
GLOBENEWSWIRE
Tourmaline Bio to Present at Upcoming Investor Conferences
01 Nov 2023 //
GLOBENEWSWIRE
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics
19 Oct 2023 //
GLOBENEWSWIRE
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline
17 Oct 2023 //
GLOBENEWSWIRE
Talaris Declares Dividend In Connection with Proposed Merger with Tourmaline
06 Oct 2023 //
GLOBENEWSWIRE
Tourmaline Bio Appoints Gerhard Hagn as SVP
20 Sep 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support